Factors related to the approval, development and publication of research protocols in a paediatric hospital;Factores asociados con la aprobación, desarrollo y publicación de proyectos de investigación en un hospital pediátrico

Archivos Argentinos de Pediatria

Volumn 107, Issue 6, 2009, Pages 504-509

  Rodríguez, Susana Patricia ^a   Vassallo, Juan Carlos ^a   Berlin, Valeria ^a   Kulik, Virginia ^a   Grenovillea, Mario ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Clinical protocoles; Publications

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; METHODOLOGY; PEDIATRIC HOSPITAL; PUBLICATION; RESEARCH;

CLINICAL PROTOCOLS; HOSPITALS, PEDIATRIC; HUMANS; PUBLISHING;

EID: 75749092964     PISSN: 03250075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. National Commission for the Protection of Human Subject of Biomedical and Behavioural Research. The Belmont Report. Washington DC. US Govermment. Panting Office, 1979. [Consulta 21 de junio de 2008]. Disponible en: http://www.nihtraining.com/ohsrsite/guidelines/belmont.html.
2. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. [Consulta: octubre de 2004]. Disponible en: htpp://www.wma.net/s/policy/b3.htm.
3. International Conference on Harmonisation Guideline for Good Clinical Practice (E6). (ICH Guideline For GCP). ICH of Technical Requirements for Registration of Pharmaceuticals for Human Use; 1996.
4. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT). Disposición 5330/97:Buenas prácticas de farmacología en investigación clínica. [Acceso: octubre 2008]. Disponible en: http://www.anmat.gov.ar.
5. Guía de Buenas Prácticas en Investigación Clínica en Seres Humanos. Resolucion 1490/2007 Ministerio de Salud. Boletín Oficial 14/11/2007. [Acceso: 18-8-2008]. Disponible en: http://test.e-legis-ar.msal.gov.ar.
6. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs. Pediatrics 1995;95(2):286-294.
7. Best pharmaceuticals for children. Act Public Law No 107-109 (January 4, 2002). [Acceso: 21-1-2007]. Disponible en: http://www.fda.gOv/Cder/pediatric/ index.htm#bpca.
8. Montané E, Vidal X. Fate of the abstracts presented at three Spanish clinical pharmacology congresses and reasons for unpublished research. Eur J Clin Pharmacol 2007;63:103-111.
9. Sanossian N, Arbi G, Ohanian M, et al. Frequency and determinants of nonpublication of research in the stroke literature. Stroke 2006; 37: 2588-2592.
10. Scherer RW, Langenberg P, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database of Syst Rev 2007; 18(2): MR 0000005.
11. von Elm E, Costanza M, Walder B et al. More insight into the fate of biomedical meeting abstracts: a systematic review. BMC Med Res Methodol 2003;3:12.
12. Weber EJ, Callahan ML, Wears RL, et al. Unpublished research from a medical speciality meeting: why investigators fail to publish. JAMA 1998;280(3):257-259.
13. Sprague S, Bhandari M, Devereaux M, et al. Barriers to full text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg 2003;85(1):158-163.
14. Carroll AE, Sox CM, Tarini BA, et al. Does presentation format at the Pediatric Academic Societies' annual meeting predict subsequent publication? Pediatrics 2003;112:1238-41.
15. Riordan FA. Do presenters to paediatrics meetings get their work published? Arch Dis Child 2000;83:524-526.
16. Christakis DA, Rivara FP. Publication ethics: editors' perspectives. J Pediatr 2006;149(1 Suppl):S39-S42.
17. Martinez Castaldi C, Silverstein M, Bauchner H. Child versus adult research: the gap in high quality study designs. Pediatrics 2008;122(1):52-57.
18. Lee KP, Boyd EA, Holroyd Leduc JM, et al. Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals. T Med J Aust 2006;184(12):621-626.
19. Hopewell S, Mc Donald S, Clarke M, Egger M. Grey literature in meta-analysis of randomized trials of health care interventions. Cochrane Database Syst Rev 2007;(2)-MR000010.
20. Hartling L, Craig WR, Russell K, et al. Factors influencing the publication of randomized controlled trials in child health research. Arch Pediatr Adolesc Med 2004;158(10):983-7.
21. Angell M. The pharmaceutical industry; to whom is it accountable? N Engl J Med 2000;342:1902-1904.
22. Sutton AJ, Duval SJ, Tweedie R, et al. Empirical assessment of effect of publication bias on metanalysis. BMJ 2000;320(7249):1574-7.
23. Krleza-Jeric K, Chan AW, Dickersin K, et al. Principles for the international registration of protocol information and results from human trials of health related interventions. BMJ 2005;330(7497):956-8.